Exact Mass: 475.1889
Exact Mass Matches: 475.1889
Found 156 metabolites which its exact mass value is equals to given mass value 475.1889
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Codeine-6-glucuronide
Codeine-6-glucuronide (C6G) is a major active metabolite of codeine and may be responsible for as much as 60\\% of the analgesic effects of codeine. C6G exhibits decreased immunosuppressive effects compared to codeine. During its metabolism, codeine is conjugated with glucuronic acid by the enzyme UDP-Glucuronosyltransferase-2B7 (UGT2B7) to form codeine-6-glucuronide. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
OA-6129 D
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Pivmecillinam hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Pipotiazine
Pipotiazine has actions similar to those of other phenothiazines. Among the different phenothiazine derivatives, it appears to be less sedating and to have a weak propensity for causing hypotension or potentiating the effects of CNS depressants and anesthetics. However, it produces a high incidence of extra pyramidal reactions. It is used for the maintenance treatment of chronic non-agitated schizophrenic patients. Symptoms of overdose include severe extrapyramidal manifestations, hypotension, lethargy and sedation. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Arzoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
N-trans-feruloyl tyramine-4-O-beta-D-glucopyranoside
MLS002154128-01!Pivmecillinam hydrochloride32887-03-9
Pipotiazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Ala Cys Pro Trp
Ala Cys Trp Pro
Ala Glu Glu Gln
Ala Glu Gln Glu
Ala Pro Cys Trp
Ala Pro Trp Cys
Ala Gln Glu Glu
Ala Trp Cys Pro
Ala Trp Pro Cys
Cys Ala Pro Trp
Cys Ala Trp Pro
Cys Pro Ala Trp
Cys Pro Trp Ala
Cys Trp Ala Pro
Cys Trp Pro Ala
Asp Asp Ile Asn
Asp Asp Leu Asn
Asp Asp Asn Ile
Asp Asp Asn Leu
Asp Asp Gln Val
Asp Asp Val Gln
Asp Glu Asn Val
Asp Glu Val Asn
Asp Ile Asp Asn
Asp Ile Asn Asp
Asp Leu Asp Asn
Asp Leu Asn Asp
Asp Asn Asp Ile
Asp Asn Asp Leu
Asp Asn Glu Val
Asp Asn Ile Asp
Asp Asn Leu Asp
Asp Asn Val Glu
Asp Gln Asp Val
Asp Gln Val Asp
Asp Val Asp Gln
Asp Val Glu Asn
Asp Val Asn Glu
Asp Val Gln Asp
Glu Ala Glu Gln
Glu Ala Gln Glu
Glu Asp Asn Val
Glu Asp Val Asn
Glu Glu Ala Gln
Glu Glu Gln Ala
Glu Asn Asp Val
Glu Asn Val Asp
Glu Gln Ala Glu
Glu Gln Glu Ala
Glu Val Asp Asn
Glu Val Asn Asp
Ile Asp Asp Asn
Ile Asp Asn Asp
Ile Asn Asp Asp
Leu Asp Asp Asn
Leu Asp Asn Asp
Leu Asn Asp Asp
Asn Asp Asp Ile
Asn Asp Asp Leu
Asn Asp Glu Val
Asn Asp Ile Asp
Asn Asp Leu Asp
Asn Asp Val Glu
Asn Glu Asp Val
Asn Glu Val Asp
Asn Ile Asp Asp
Asn Leu Asp Asp
Asn Val Asp Glu
Asn Val Glu Asp
Pro Ala Cys Trp
Pro Ala Trp Cys
Pro Cys Ala Trp
Pro Cys Trp Ala
Pro Trp Ala Cys
Pro Trp Cys Ala
Gln Ala Glu Glu
Gln Asp Asp Val
Gln Asp Val Asp
Gln Glu Ala Glu
Gln Glu Glu Ala
Gln Val Asp Asp
Val Asp Asp Gln
Val Asp Glu Asn
Val Asp Asn Glu
Val Asp Gln Asp
Val Glu Asp Asn
Val Glu Asn Asp
Val Asn Asp Glu
Val Asn Glu Asp
Val Gln Asp Asp
Trp Ala Cys Pro
Trp Ala Pro Cys
Trp Cys Ala Pro
Trp Cys Pro Ala
Trp Pro Ala Cys
Trp Pro Cys Ala
Trelagliptin succinate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Atevirdine mesylate
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
N-caffeoyl O-methyltyramine-4-O-beta-D-glucopyranoside
Selexid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Asn-Leu-Asp-Asp
A tetrapeptide composed of L-asparagine, L-leucine and two L-aspartic acid units joined in sequence by peptide linkages.
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-[4-(1-pyrrolidinylsulfonyl)phenyl]benzamide
2-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
4-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methylimidazole-4-sulfonamide
N,N-dimethyl-4-[4-[(1R,5S)-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
N,N-dimethyl-4-[4-[(1S,5R)-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
N,N-dimethyl-3-[4-[(1R,5S)-6-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
N,N-dimethyl-3-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
Codeine-6-glucuronide
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
(2S,3S,5R,6R)-3-[2-[3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-methoxyestrone 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of 2-methoxyestrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.